NewCardio Adds Gari Clifford, Ph.D., to Technology Development Team

SAN JOSE, Calif.--(BUSINESS WIRE)--NewCardio, Inc., (OTCBB: NWCI) a development-stage cardiac diagnostic and services company, today announced that it has entered into a long-term consulting agreement with Gari Clifford, Ph.D. Under terms of the agreement, Dr. Clifford will assist with the development of the Company’s platform technology in collaboration with NewCardio’s technology team.
MORE ON THIS TOPIC